Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10.70x is 27% above its 1-year average of -14.65x, near the high end of its 1-year range (-15.76x–-10.70x).
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-10.70x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-154.76%
vs the sector median at left
Basel Medical Group Ltd Ordinary Shares
Market Cap
$5.26M
Interest Coverage Ratio
-10.70x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.81M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.85M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.58M
Interest Coverage Ratio
N/A
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$5.36M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
Market Cap
$4.50M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.40M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Basel Medical Group Ltd Ordinary Shares (BMGL) | $5.26M | -10.70x | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.81M | -2.90x | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -16.26x | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.21M | N/A | 1.00x | 1.02x | 1.02x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.58M | N/A | 1.10x | 1.10x | 1.10x |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | -765.53x | 1.76x | 1.76x | 1.76x |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.49M | -345.15x | 1.19x | 1.19x | 1.19x |
Interest Coverage
-10.7x
Debt/Equity
1.57
Current Ratio
1.88
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -13.54x |
| 2025-06-30 | -15.76x |
